The Center for Innovative GYN Care® (CIGC®) co-founders, Dr. Paul MacKoul and Dr. Natalya Danilyants announced today that a Company abstract has been accepted for a presentation at this year’s ASRM Scientific Congress and Expo.
| WASHINGTON, Oct. 16, 2019 /PRNewswire/ -- The Center for Innovative GYN Care® (CIGC®) co-founders, Dr. Paul MacKoul and Dr. Natalya Danilyants announced today that a Company abstract has been accepted for a presentation at this year’s ASRM Scientific Congress and Expo. The presentation, titled, “Impact of Safety Protocol in an Ambulatory Surgical Setting vs. a Hospital Setting for Laparoscopic-Assisted Myomectomy (LAAM),” will take place on October 16, 2019, at 6:30 a.m. local time in the Expo Hall at the Pennsylvania Convention Center in Philadelphia. When comparing laparoscopic-assisted myomectomies (LAAM) in an ambulatory surgery center (ASC) to those being performed in a hospital setting, CIGC’s analysis found that there were no statistically significant differences in intra- or post-operative complications between the ASC and hospital setting, including infections and thromboembolic events. The study also concluded that the safety protocol at a free-standing ASC allows for patient outcomes that are not only comparable to an in-hospital setting but are also without apparent limitations in case complexity, including fibroid weight, BMI, number of previous abdominal and pelvic surgeries or other comorbidities. The study analyzed 588 patients who underwent LAAM at an ASC, compared with 288 patients who underwent LAAM at a hospital. The intra-operative complication rate was 3.4 percent at the ASC, compared with 4.9 percent at the hospital (p=0.4430). “With over 30,000 women undergoing laparoscopic-assisted myomectomies each year, the data collected from this study is significant, because it shows that ambulatory surgical centers, including those utilized by CIGC patients, have many noteworthy advantages over hospital facilities – all the while offering the same safety profile for similar surgeries,” said Dr. Louise van der Does, CIGC Director of Research and Public Policy. “What’s more, with a lower overhead and no overnight patients, a visit to an ASC often costs significantly less than a hospital visit. CIGC’s mission is to provide world-class, innovative gynecological surgical treatments in a setting that offers both efficacy and comfort for the patient. ASCs are the definition of value-based care and represent the future of medicine as we know it today.” “As GYN care is one of the highest volume surgical specialties in the U.S. today, these centers are often equipped with the newest, most innovative medical procedures, such as DualPortGYN® and LAAM®, which result in smaller incision sizes, fewer complications, much higher patient satisfaction rates and a more comfortable, convenient setting,” added Paul MacKoul MD, CIGC Co-Founder. “As a result, GYN-centric ASCs are the new wave for surgery centers, allowing for focused care in one specialty with the potential to help millions of women all over the world.” The ASRM Scientific Congress and Expo is the premier education and research meeting for reproductive medicine and features the top experts discussing the latest in reproductive care. About The Center for Innovative GYN Care About Dr. Paul MacKoul SOURCE The Center for Innovative GYN Care |
View original content:
